Visit other SMART + STRONG sites:
AIDSMEDSREAL HEALTHTU SALUD
Subscribe to:
POZ magazine
E-newsletters
POZ Personals
Sign In / Join
Username:
Password:

Back to home » News » August 2005

Web Exclusives

My Future at NMAC

Puckering Up for AIDS Awareness

AIDSmeds in San Francisco: Highlights from CROI 2010

» More

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

10 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrsswidgetprint

August 29, 2005

When to Start Meds: How’s Your Math?

by Staff

Monday, August 29, 2005—If your CD4 count is over 350, you don't need to start meds yet, right? Not so fast, says a new study in the September 15 Journal of Infectious Diseases that found CD4 “percentage”—the proportion of your lymphocytes that are CD4s, basically the lymphocytes in charge—more relevant than CD4 count alone. In the study, the group of first-combo HIVers with CD4 lymphocyte percentages under 17% had faster-progressing HIV. If these results pan out in further tests, the old feud from pre-combo days could flare up between docs who go with percentage as the best predictor of immune health and docs who prefer the CD4 count. Keep a calculator handy.

emailrsswidgetprint


[Go to top]

Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Community
Advocacy
Job Listings
Events Calendar
Starting Treatment
My Cool Tools


    chistud27
    Chicago
    Illinois


    sillygurl
    baytown
    Texas


    brasilnj
    Newark
    New Jersey


    ifeekes
    san antonio
    Texas
Click here to join POZ Personals!
Talk to Us
Poll
Question: Are women especially vulnerable to contracting HIV?
Yes
No

Survey
Peace of Mind

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy